European Medicines Agency decision on the refusal of a product specific waiver for 18F fluoromisonid
A waiver for 18F fluoromisonidazole, solution for injection, intravenous use, the details of which are set
out in the opinion of the Paediatric Committee of the European Medicines Agency annexed hereto,
together with its appendices, is hereby refused.
